9BP1 image
Deposition Date 2024-05-06
Release Date 2025-01-15
Last Version Date 2025-01-22
Entry Detail
PDB ID:
9BP1
Title:
Rhesus macaque ITS110.01 Fab in complex with SIV Env MPER peptide
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.58 Å
R-Value Free:
0.26
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 62
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:ITS110.01 Heavy Chain
Chain IDs:A, E (auth: H)
Chain Length:232
Number of Molecules:2
Biological Source:Macaca mulatta
Polymer Type:polypeptide(L)
Molecule:ITS110.01 Light Chain
Chain IDs:B, F (auth: D)
Chain Length:214
Number of Molecules:2
Biological Source:Macaca mulatta
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp160
Gene (Uniprot):env
Chain IDs:C (auth: I), D (auth: E)
Chain Length:27
Number of Molecules:2
Biological Source:Simian immunodeficiency virus
Ligand Molecules
Primary Citation
Isolation and structure of broad SIV-neutralizing antibodies reveal a proximal helical MPER epitope recognized by a rhesus multi-donor class.
Cell Rep 44 115163 115163 (2025)
PMID: 39792559 DOI: 10.1016/j.celrep.2024.115163

Abstact

The membrane-proximal external region (MPER) of the HIV-1 envelope is a target for broadly neutralizing antibodies (bnAbs), and vaccine-elicited MPER-directed antibodies have recently been reported from a human clinical trial. In this study, we sought to identify MPER-directed nAbs in simian immunodeficiency virus (SIV)-infected rhesus macaques. We isolated four lineages of SIV MPER-directed nAbs from two SIV-infected macaques. The nAbs displayed low potency but up to 90% breadth on a 20-strain SIV panel. Crystal structures of representative nAbs in complex with SIV MPER peptides revealed the SIV antibodies to bind a helical epitope at the N-terminal (proximal) region of the MPER, defining a reproducible multi-donor class encompassing all four lineages. HIV-1 comparison showed that this class of SIV MPER-directed antibodies targets a helical region overlapping that targeted by human vaccine-elicited ones. Thus, a prevalent and reproducible class of SIV bnAbs recognizes an epitope similar to that recently observed in an HIV-1-vaccine trial.

Legend

Protein

Chemical

Disease

Primary Citation of related structures